{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T02:04:28Z","timestamp":1773885868967,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T00:00:00Z","timestamp":1655424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T00:00:00Z","timestamp":1655424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s12010-022-04014-3","type":"journal-article","created":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T09:10:07Z","timestamp":1655457007000},"page":"5185-5195","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Association of VEGF Gene Polymorphism (rs699947) with Glaucoma and In-Silico Study of Antiglaucoma Bioactive Compounds"],"prefix":"10.1007","volume":"194","author":[{"given":"Nageen","family":"Hussain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia Falek","family":"Sher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuming","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Adil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,17]]},"reference":[{"issue":"5","key":"4014_CR1","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1136\/bjo.80.5.389","volume":"80","author":"HA Quigley","year":"1996","unstructured":"Quigley, H. A. (1996). Number of people with glaucoma worldwide. British Journal Of Ophthalmology, 80(5), 389\u2013393.","journal-title":"British Journal Of Ophthalmology"},{"key":"4014_CR2","doi-asserted-by":"publisher","first-page":"S151","DOI":"10.1016\/S0039-6257(99)00029-6","volume":"43","author":"RW Nickells","year":"1999","unstructured":"Nickells, R. W. (1999). Apoptosis of retinal ganglion cells in glaucoma: An update of the molecular pathways involved in cell death. Survey of ophthalmology, 43, S151\u2013S161.","journal-title":"Survey of ophthalmology."},{"issue":"17","key":"4014_CR3","doi-asserted-by":"publisher","first-page":"9944","DOI":"10.1073\/pnas.96.17.9944","volume":"96","author":"AH Neufeld","year":"1999","unstructured":"Neufeld, A. H., Sawada, A., & Becker, B. (1999). Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proceedings of the National Academy of Sciences, 96(17), 9944\u20139948.","journal-title":"Proceedings of the National Academy of Sciences."},{"key":"4014_CR4","volume-title":"Shields' textbook of glaucoma","author":"MB Shields","year":"2005","unstructured":"Shields, M. B., Allingham, R. R., & Damji, K. F. (2005). Shields\u2019 textbook of glaucoma. Hamilton Glaucoma Center, University of California, San Diego, La Jolla, CA: Lippincott Williams & Wilkins."},{"issue":"4","key":"4014_CR5","first-page":"812","volume":"63","author":"A Stevens","year":"2003","unstructured":"Stevens, A., Soden, J., Brenchley, P. E., Ralph, S., & Ray, D. W. (2003). Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer Research, 63(4), 812\u2013816.","journal-title":"Cancer Research"},{"issue":"3","key":"4014_CR6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.lungcan.2004.04.037","volume":"46","author":"MI Koukourakis","year":"2004","unstructured":"Koukourakis, M. I., Papazoglou, D., Giatromanolaki, A., Bougioukas, G., Maltezos, E., & Siviridis, E. (2004). VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer. Lung Cancer, 46(3), 293\u2013298.","journal-title":"Lung Cancer"},{"key":"4014_CR7","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1167\/iovs.18-26364","volume":"60","author":"T Shen","year":"2019","unstructured":"Shen, T., Gupta, V. K., Klistorner, A., Chitranshi, N., Graham, S. L., & You, Y. (2019). Sex-specific effect of BDNF Val66Met genotypes on the progression of open-angle glaucoma. Investigative Ophthalmology & Visual Science, 60, 1069\u20131075.","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"15","key":"4014_CR8","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1001\/jama.290.15.2057","volume":"290","author":"NG Congdon","year":"2003","unstructured":"Congdon, N. G., Friedman, D. S., & Lietman, T. (2003). Important causes of visual impairment in the world today. JAMA, 290(15), 2057\u20132060.","journal-title":"JAMA"},{"issue":"12","key":"4014_CR9","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1136\/bjo.72.12.881","volume":"72","author":"J Jay","year":"1998","unstructured":"Jay, J., & Murray, S. (1998). Early trabeculectomy versus conventional management in primary open angle glaucoma. British Journal Of Ophthalmology, 72(12), 881\u2013889.","journal-title":"British Journal Of Ophthalmology"},{"issue":"10","key":"4014_CR10","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1093\/hmg\/6.10.1667","volume":"6","author":"M Sarfarazi","year":"1997","unstructured":"Sarfarazi, M. (1997). Recent advances in molecular genetics of glaucomas. Human Molecular Genetics, 6(10), 1667\u20131677.","journal-title":"Human Molecular Genetics"},{"issue":"9","key":"4014_CR11","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/S0140-6736(04)16257-0","volume":"363","author":"RN Weinreb","year":"2004","unstructured":"Weinreb, R. N., & Khaw, P. T. (2004). Primary open-angle glaucoma. The Lancet, 363(9), 1711\u20131720.","journal-title":"The Lancet."},{"issue":"4","key":"4014_CR12","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1076\/opep.5.4.173.4192","volume":"5","author":"MW Tuck","year":"1998","unstructured":"Tuck, M. W., & Crick, R. P. (1998). The age distribution of primary open angle glaucoma. Ophthalmic Epidemiology, 5(4), 173\u2013183.","journal-title":"Ophthalmic Epidemiology."},{"issue":"4","key":"4014_CR13","first-page":"22","volume":"13","author":"S Hoh","year":"2001","unstructured":"Hoh, S., Gazzard, G., Oen, F., & Seah, S. (2001). Laser iridotomy versus primary phacoemulsification. Asia Pacific Journal Ophthalmology, 13(4), 22\u201323.","journal-title":"Asia Pacific Journal Ophthalmology"},{"issue":"7","key":"4014_CR14","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1210\/jc.2009-2719","volume":"95","author":"M-Y Chun","year":"2010","unstructured":"Chun, M.-Y., Hwang, H.-S., Cho, H.-Y., Chun, H.-J., Woo, J.-T., Lee, K.-W., & Park, Y. (2010). Association of vascular endothelial growth factor polymorphisms with nonproliferative and proliferative diabetic retinopathy. The Journal of Clinical Endocrinology & Metabolism, 95(7), 3547\u20133551.","journal-title":"The Journal of Clinical Endocrinology & Metabolism."},{"issue":"3","key":"4014_CR15","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.bbrc.2005.05.167","volume":"333","author":"T Awata","year":"2005","unstructured":"Awata, T., Kurihara, S., Takata, N., Neda, T., Iizuka, H., Ohkubo, T., & Inukai, K. (2005). Functional VEGF C-634G polymorphism is associated with development of diabetic macular edema and correlated with macular retinal thickness in type 2 diabetes. Biochemical and Biophysical Research Communications, 333(3), 679\u2013685.","journal-title":"Biochemical and Biophysical Research Communications."},{"issue":"12","key":"4014_CR16","doi-asserted-by":"publisher","first-page":"5552","DOI":"10.1167\/iovs.09-3694","volume":"50","author":"S Abhary","year":"2009","unstructured":"Abhary, S., Burdon, K. P., Gupta, A., Lake, S., Selva, D., Petrovsky, N., & Craig, J. E. (2009). Common sequence variation in the VEGFA gene predicts risk of diabetic retinopathy. Investigative Ophthalmology & Visual Science, 50(12), 5552\u20135558.","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"1","key":"4014_CR17","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1681\/ASN.V131260","volume":"13","author":"M Shahbazi","year":"2002","unstructured":"Shahbazi, M., Fryer, A. A., Pravica, V., Brogan, I. J., Ramsay, H. M., Hutchinson, I. V., & Harden, P. N. (2002). Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. Journal of the American Society of Nephrology, 13(1), 260\u2013264.","journal-title":"Journal of the American Society of Nephrology"},{"key":"4014_CR18","unstructured":"James C and Natalie S (2014) Microbiology. A laboratory manual 2014: Pearson Education"},{"issue":"10","key":"4014_CR19","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1042\/CS20210040","volume":"135","author":"CT Supuran","year":"2021","unstructured":"Supuran, C. T. (2021). Emerging role of carbonic anhydrase inhibitors. Clinical Science, 135(10), 1233\u20131249.","journal-title":"Clinical Science."},{"key":"4014_CR20","doi-asserted-by":"publisher","first-page":"112285","DOI":"10.1016\/j.indcrop.2020.112285","volume":"148","author":"M Imran","year":"2020","unstructured":"Imran, M., et al. (2020). Carbonic anhydrase and cholinesterase inhibitory activities of isolated flavonoids from Oxalis corniculata L and their first-principles investigations. Industrial Crops and Products, 148, 112285.","journal-title":"Industrial Crops and Products"},{"issue":"5","key":"4014_CR21","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1089\/jop.2007.0036","volume":"23","author":"ME Gheith","year":"2007","unstructured":"Gheith, M. E., Siam, G. A., de Barros, D. S., Garg, S. J., & Moster, M. R. (2007). Role of intravitreal bevacizumab in neovascular glaucoma. Journal of Ocular Pharmacology and Therapeutics, 23(5), 487\u2013491.","journal-title":"Journal of Ocular Pharmacology and Therapeutics"},{"issue":"29","key":"4014_CR22","doi-asserted-by":"publisher","first-page":"8804","DOI":"10.12998\/wjcc.v9.i29.8804","volume":"9","author":"HS Kim","year":"2021","unstructured":"Kim, H. S., et al. (2021). Is mannitol combined with furosemide a new treatment for refractory lymphedema? A case report. World Journal of Clinical Cases, 9(29), 8804.","journal-title":"World Journal of Clinical Cases."},{"issue":"8","key":"4014_CR23","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.3390\/nu13082800","volume":"13","author":"F-J Cheng","year":"2021","unstructured":"Cheng, F.-J., et al. (2021). Hesperidin is a potential inhibitor against SARS-CoV-2 infection. Nutrients, 13(8), 2800.","journal-title":"Nutrients"},{"issue":"5","key":"4014_CR24","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1080\/17425247.2021.1846518","volume":"18","author":"DS Sharma","year":"2021","unstructured":"Sharma, D. S., et al. (2021). Recent advances in intraocular and novel drug delivery systems for the treatment of diabetic retinopathy. Expert Opinion on Drug Delivery, 18(5), 553\u2013576.","journal-title":"Expert Opinion on Drug Delivery."},{"key":"4014_CR25","first-page":"1","volume":"21","author":"A Arbabi","year":"2021","unstructured":"Arbabi, A., et al. (2021). Systemic side effects of glaucoma medications. Clinical and Experimental Optometry, 21, 1\u20139.","journal-title":"Clinical and Experimental Optometry"},{"issue":"3","key":"4014_CR26","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/bjo.2005.081224","volume":"90","author":"HA Quigley","year":"2006","unstructured":"Quigley, H. A., & Broman, A. T. (2006). The number of people with glaucoma worldwide in 2010 and 2020. British Journal Of Ophthalmology, 90(3), 262\u2013267.","journal-title":"British Journal Of Ophthalmology"},{"issue":"11","key":"4014_CR27","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1056\/NEJMra0804630","volume":"360","author":"YH Kwon","year":"2009","unstructured":"Kwon, Y. H., Fingert, J. H., Kuehn, M. H., & Alward, W. L. (2009). Primary open-angle glaucoma. New England Journal of Medicine, 360(11), 1113\u20131124.","journal-title":"New England Journal of Medicine."},{"issue":"7","key":"4014_CR28","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1001\/archopht.116.7.861","volume":"116","author":"BL Lee","year":"1998","unstructured":"Lee, B. L., Gutierrez, P., Gordon, M., Wilson, M. R., Cioffi, G. A., Ritch, R., & Mangione, C. M. (1998). The Glaucoma Symptom Scale: A brief index of glaucoma-specific symptoms. Archives of Ophthalmology, 116(7), 861\u2013866.","journal-title":"Archives of Ophthalmology"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-022-04014-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-022-04014-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-022-04014-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T04:51:29Z","timestamp":1666327889000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-022-04014-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,17]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["4014"],"URL":"https:\/\/doi.org\/10.1007\/s12010-022-04014-3","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,17]]},"assertion":[{"value":"27 May 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This project has been evaluated and approved by the Departmental Research Ethics and Biosafety Committee. The committee could not find any biosafety and ethical concerns related to the proposed work and its execution at the Institute of Microbiology and Molecular Genetics, University of the Punjab, Lahore.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All the participants involved in the study had their consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"It is certified that the \u201cAssociation of <i>VEGF<\/i> Gene Polymorphism (rs699947) with Glaucoma and In Silico Study of Antiglaucoma Bioactive Chemicals\u201d has neither been published in any journal nor copied from anywhere else. The authors of this original article want to submit it in this journal.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}